couter

BICTFBiocure Technology Inc.

Oct 15, 2026 — Critical Capital Raise / Equity Dilution
Chart by TradingView

The schedule

  • Thu15Oct

    Anticipated financing event to sustain operations given ongoing cash burn and microscopic valuation.

  • Tue15Dec
  • Wed10Feb

    Expected update on clinical trials, biosimilar portfolio progress, or potential out-licensing deals.

  • Tue15Jun

    Q3 2026 financials providing an update on quarterly burn rate and strategic alternatives.

  • Tue14Sep

    Full-year 2026 results and audit opinions regarding going-concern feasibility.

Past

  • Tue15Sep

    Expected announcement of Q2 2026 financial results, focusing heavily on runway and going-concern status.